GCMI and T3 Labs’ new web presence and branding

Dear customers, vendors, colleagues and friends, It is with great pleasure that we announce our newly integrated and rebranded GCMI website, www.gcmiatl.org. This new website gives a comprehensive look at all our service lines: Design & Development Preclinical Testing and Bioskills Training Lifecycle Advisory This website and our new organizational look and feel is a result…

American Cancer Society and Global Center for Medical Innovation Partner to Accelerate Pace of Bringing Research to Clinic

The American Cancer Society (ACS) is partnering with the Atlanta-based Global Center for Medical Innovation (GCMI) to more rapidly bring groundbreaking research from the lab to the clinic. The American Cancer Society conducts research and funds research through grants to hundreds of scientists and health professionals nationwide. Bridging the gap between early research and actual…

A venture gathering you won’t want to miss: and a VIP discount code for the GCMI ecosystem

  Venture Summit West 2018 – Where Innovation Meets Capital March 13th – 14th, 2018 | Santa Clara Convention Center | Silicon Valley Friends, GCMI is pleased to announce its sponsorship and invite you to attend Venture Summit West 2018. Whether you’re a startup seeking capital and exposure, or an investor seeking new deals, Venture Summit | West presented by youngStartup Ventures is one event you won’t want to miss.…

GCMI 2017 Year In Review

We want to begin by wishing you and your team, a joyous and safe holiday season. Thank you for all your support and the opportunities you have sent our way.  We hope you all get to enjoy this time with your loved ones. In so many ways, 2017 was a landmark year for GCMI. From…

Supporting the development of new Point of Care (POC) technologies with IEEE and NIH

Michael Fisher, Director of Product Development for GCMI, shares his insights from the IEEE-NIH Healthcare Innovations and Point of Care Technology conference. Recently, GCMI attended and spearheaded a presentation during the IEEE-NIH Healthcare Innovations and Point of Care Technology conference which focuses on innovation and technologies for precision health and their clinical translation, to address…

Engaging a flexible third party medical product development firm to help you tackle an inflexible process

Medical technology innovators learn quickly that there is little, if any, flexibility in the FDA approval process. NFANT Labs knew they needed multidisciplinary partners able to build flexibility into an inflexible process, designing and developing their product with a constant eye on efficiency and the FDA approval prize. In the United States, up to 70%…